Abstract
Pancreatic cancer, glioblastoma, and melanoma pose significant challenges in the oncology field, with considerable mortality rates and complexities in clinical management. Despite advancements in understanding tumorigenic mechanisms, therapeutic resistance, especially related to cancer stem cells (CSCs), remains an obstacle. Considering the impact of long non-coding RNAs (lncRNAs) on biol…